Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiMauro

Showing results (891-900 of 942) with videos related to

Pageof 95
Sort By:
ACS Medicinal Chemistry Letters|May 14, 2025
The Discovery of Bridged Benzoazepine Amides as Selective Allosteric Modulators of RIPK1Joanna L Chen, Joey L Methot, Matthew J Mitcheltree, et al.
Journal of Medicinal Chemistry|December 22, 2016
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine ReceptorsHoward Bregman, Jeffrey R Simard, Kristin L Andrews, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool CompoundsBrandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.
Physical Review Letters|September 28, 2010
Ultraintense x-ray induced ionization, dissociation, and frustrated absorption in molecular nitrogenM Hoener, L Fang, O Kornilov, et al.
Nature|July 3, 2010
Femtosecond electronic response of atoms to ultra-intense X-raysL Young, E P Kanter, B Krässig, et al.
Journal of Medicinal Chemistry|June 4, 2011
Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent painHoward Bregman, Loren Berry, John L Buchanan, et al.
Journal of Medicinal Chemistry|August 6, 2008
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonistsYuan Cheng, Brian K Albrecht, James Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2013
Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemiaIrini Manoli, Justin R Sysol, Lingli Li, et al.
Diabetes|September 10, 1999
Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasisW K Chung, A Luke, R S Cooper, et al.
Pageof 95

Showing results (891-900 of 942) with videos related to

Sort By:
Pageof 95
ACS Medicinal Chemistry Letters|May 14, 2025
The Discovery of Bridged Benzoazepine Amides as Selective Allosteric Modulators of RIPK1Joanna L Chen, Joey L Methot, Matthew J Mitcheltree, et al.
Journal of Medicinal Chemistry|December 22, 2016
The Discovery and Hit-to-Lead Optimization of Tricyclic Sulfonamides as Potent and Efficacious Potentiators of Glycine ReceptorsHoward Bregman, Jeffrey R Simard, Kristin L Andrews, et al.
ACS Medicinal Chemistry Letters|April 16, 2021
Discovery of Diaminopyrimidine Carboxamide HPK1 Inhibitors as Preclinical Immunotherapy Tool CompoundsBrandon A Vara, Samuel M Levi, Abdelghani Achab, et al.
Bioorganic & Medicinal Chemistry Letters|November 19, 2009
2,4-Diaminopyrimidine MK2 inhibitors. Part I: Observation of an unexpected inhibitor binding modeMaria A Argiriadi, Anna M Ericsson, Christopher M Harris, et al.
Physical Review Letters|September 28, 2010
Ultraintense x-ray induced ionization, dissociation, and frustrated absorption in molecular nitrogenM Hoener, L Fang, O Kornilov, et al.
Nature|July 3, 2010
Femtosecond electronic response of atoms to ultra-intense X-raysL Young, E P Kanter, B Krässig, et al.
Journal of Medicinal Chemistry|June 4, 2011
Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent painHoward Bregman, Loren Berry, John L Buchanan, et al.
Journal of Medicinal Chemistry|August 6, 2008
Discovery and optimization of a novel series of N-arylamide oxadiazoles as potent, highly selective and orally bioavailable cannabinoid receptor 2 (CB2) agonistsYuan Cheng, Brian K Albrecht, James Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2013
Targeting proximal tubule mitochondrial dysfunction attenuates the renal disease of methylmalonic acidemiaIrini Manoli, Justin R Sysol, Lingli Li, et al.
Diabetes|September 10, 1999
Genetic and physiologic analysis of the role of uncoupling protein 3 in human energy homeostasisW K Chung, A Luke, R S Cooper, et al.
Pageof 95